BENEFITS OF RILPIVIRINE FOR LIVER FIBROSIS IN HIV/HCV COINFECTED SUBJECTS
Recent studies have described that treatment with rilpivirine (RPV) induces antifibrotic effects in various models of chronic liver disease1. Our objective was to analyse whether HIV-infected patients with some degree of liver stiffness measured by transition elastography (TE) and treated with RPV-based regimens showed any improvement. 1. Martí-Rodrigo A, Alegre F, Moragrega ÁB, et al. Gut epub ahead…